Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Hippocampal Activity in Psychosis
NCT04559529Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in psychosis, schizophrenia, sponsored by Vanderbilt University Medical Center. Started Sep 2020; status: completed.
02
Drugs
levetiracetam
03
Conditions
psychosisschizophrenia
Beyond the preview
Go deeper on NCT04559529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04559529.